Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Rilpivirine> ?p ?o }
- Rilpivirine abstract "Rilpivirine (TMC278, trade name Edurant) is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.Rilpivirine entered phase III clinical trials in April 2008, and was approved for use in the United States in May 2011. A fixed-dose drug combining rilpivirine with emtricitabine and tenofovir, was approved by the U.S. Food and Drug Administration in August 2011 under the brand name Complera; it was licensed in the European Union under the brand name Eviplera in November 2011.Like etravirine, a second-generation NNRTI approved in 2008, rilpivirine is a diarylpyrimidine (DAPY). Rilpivirine in combination with emtricitabine and tenofovir has been shown to have higher rates of virologic failure than Atripla in patients with baseline HIV viral loads greater than 100,000 copies/mm3.".
- Rilpivirine thumbnail Rilpivirine.svg?width=300.
- Rilpivirine wikiPageID "14815344".
- Rilpivirine wikiPageLength "6149".
- Rilpivirine wikiPageOutDegree "22".
- Rilpivirine wikiPageRevisionID "679035577".
- Rilpivirine wikiPageWikiLink Adverse_drug_reaction.
- Rilpivirine wikiPageWikiLink Biological_half-life.
- Rilpivirine wikiPageWikiLink Category:Belgian_inventions.
- Rilpivirine wikiPageWikiLink Category:Nitriles.
- Rilpivirine wikiPageWikiLink Category:Non-nucleoside_reverse_transcriptase_inhibitors.
- Rilpivirine wikiPageWikiLink Category:Pyrimidines.
- Rilpivirine wikiPageWikiLink Diarylpyrimidines.
- Rilpivirine wikiPageWikiLink Efavirenz.
- Rilpivirine wikiPageWikiLink tenofovir.
- Rilpivirine wikiPageWikiLink Emtricitabine.
- Rilpivirine wikiPageWikiLink tenofovir.
- Rilpivirine wikiPageWikiLink Etravirine.
- Rilpivirine wikiPageWikiLink European_Union.
- Rilpivirine wikiPageWikiLink Fixed-dose_combination_(antiretroviral).
- Rilpivirine wikiPageWikiLink Food_and_Drug_Administration.
- Rilpivirine wikiPageWikiLink HIV.
- Rilpivirine wikiPageWikiLink Pharmaceutical_drug.
- Rilpivirine wikiPageWikiLink Phases_of_clinical_research.
- Rilpivirine wikiPageWikiLink Potency_(pharmacology).
- Rilpivirine wikiPageWikiLink Reverse-transcriptase_inhibitor.
- Rilpivirine wikiPageWikiLink Tenofovir_disoproxil.
- Rilpivirine wikiPageWikiLink Tibotec.
- Rilpivirine wikiPageWikiLinkText "Rilpivirine".
- Rilpivirine wikiPageWikiLinkText "rilpivirine".
- Rilpivirine atcPrefix "J05".
- Rilpivirine atcSuffix "AG05".
- Rilpivirine c "22".
- Rilpivirine casNumber "500287".
- Rilpivirine chebi "68606".
- Rilpivirine chembl "175691".
- Rilpivirine chemspiderid "4953643".
- Rilpivirine eliminationHalfLife "136800.0".
- Rilpivirine h "18".
- Rilpivirine image "Rilpivirine 3D 2zd1.png".
- Rilpivirine iupacName "4".
- Rilpivirine legalUs "Rx-only".
- Rilpivirine licenceUs "Rilpivirine".
- Rilpivirine medlineplus "a611037".
- Rilpivirine molecularWeight "366.42".
- Rilpivirine n "6".
- Rilpivirine niaidChemdb "169030".
- Rilpivirine pdbLigand "T27".
- Rilpivirine pregnancyUs "B".
- Rilpivirine pubchem "6451164".
- Rilpivirine routesOfAdministration "Oral".
- Rilpivirine stdinchi "1".
- Rilpivirine stdinchikey "YIBOMRUWOWDFLG-ONEGZZNKSA-N".
- Rilpivirine tradename "Edurant".
- Rilpivirine unii "FI96A8X663".
- Rilpivirine verifiedfields "changed".
- Rilpivirine verifiedrevid "417509820".
- Rilpivirine watchedfields "changed".
- Rilpivirine width "180".
- Rilpivirine wikiPageUsesTemplate Template:Antiinfective-drug-stub.
- Rilpivirine wikiPageUsesTemplate Template:Antiretroviral_drug.
- Rilpivirine wikiPageUsesTemplate Template:Cascite.
- Rilpivirine wikiPageUsesTemplate Template:Chemspidercite.
- Rilpivirine wikiPageUsesTemplate Template:Drugbankcite.
- Rilpivirine wikiPageUsesTemplate Template:Drugs.com.
- Rilpivirine wikiPageUsesTemplate Template:Ebicite.
- Rilpivirine wikiPageUsesTemplate Template:Fdacite.
- Rilpivirine wikiPageUsesTemplate Template:Globalize.
- Rilpivirine wikiPageUsesTemplate Template:Infobox_drug.
- Rilpivirine wikiPageUsesTemplate Template:Reflist.
- Rilpivirine wikiPageUsesTemplate Template:Stdinchicite.
- Rilpivirine subject Category:Belgian_inventions.
- Rilpivirine subject Category:Nitriles.
- Rilpivirine subject Category:Non-nucleoside_reverse_transcriptase_inhibitors.
- Rilpivirine subject Category:Pyrimidines.
- Rilpivirine hypernym Drug.
- Rilpivirine type ChemicalSubstance.
- Rilpivirine type Drug.
- Rilpivirine type Group.
- Rilpivirine type Brand.
- Rilpivirine type Chemical.
- Rilpivirine type Diazine.
- Rilpivirine type Group.
- Rilpivirine type Inhibitor.
- Rilpivirine type Nitrile.
- Rilpivirine type Redirect.
- Rilpivirine type ChemicalObject.
- Rilpivirine type Thing.
- Rilpivirine type Q8386.
- Rilpivirine comment "Rilpivirine (TMC278, trade name Edurant) is a pharmaceutical drug, developed by Tibotec, for the treatment of HIV infection. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.Rilpivirine entered phase III clinical trials in April 2008, and was approved for use in the United States in May 2011.".
- Rilpivirine label "Rilpivirine".
- Rilpivirine sameAs Q421547.
- Rilpivirine sameAs ريلبيفيرين.
- Rilpivirine sameAs Rilpivirin.
- Rilpivirine sameAs Rilpivirina.
- Rilpivirine sameAs Rilpivirine.
- Rilpivirine sameAs Rilpivirin.
- Rilpivirine sameAs Rilpivirina.
- Rilpivirine sameAs m.03gywtn.
- Rilpivirine sameAs Rilpivirin.